15
Participants
Start Date
February 2, 2023
Primary Completion Date
April 9, 2024
Study Completion Date
April 9, 2024
Quinine
Quinine, which is a bitter compound, extracted from the bark of the cinchona tree and has been shown in our previous studies to lower blood glucose in doses of 300-600 mg, will be 'active' in this condition.
L-leucine
L-leucine, which is a branched-chain amino acid, and one of the building blocks of protein, therefore is part of our daily diet, will be 'active' in this condition.
Combination of quinine and L-leucine
In this condition, both quinine and L-leucine will be administered as 'active'.
Control
In the condition, where quinine is 'active', control for L-leucine (5 ml oraplus and 95 ml saline) will be administered. In the condition, where L-leucine will be 'active', control for quinine (10 ml distilled water) will be administered.
Clinical Research Facility, Adelaide Health and Medical Sciences Building, Adelaide
University of Adelaide
OTHER